Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development

Liver cancer is a malignancy developed from underlying liver disease that encompasses liver injury and metabolic disorders. The progression from these underlying liver disease to cancer is accompanied by chronic inflammatory conditions in which liver macrophages play important roles in orchestrating the inflammatory response. During this process, bioactive lipids produced by hepatocytes and macrophages mediate the inflammatory responses by acting as pro-inflammatory factors, as well as, playing roles in the resolution of inflammation conditions. Here, we review the literature discussing the roles of bioactive lipids in acute and chronic hepatic inflammation and progression to cancer.

Automated summary

Liver cancer is a malignancy that arises from liver disease, including liver injury and metabolic disorders. The development of cancer from these liver diseases involves chronic inflammation, in which liver macrophages play significant roles. Bioactive lipids produced by hepatocytes and macrophages act as pro-inflammatory factors and contribute to the resolution of inflammation during this process. This review discusses the roles of bioactive lipids in acute and chronic hepatic inflammation and cancer progression.